Mylan Pharmaceuticals Inc., et al. vs. Sanofi Aventis Deutschland GmbH et al.
Explore the PTAB proceeding IPR2017-01526 filed by Mylan Pharmaceuticals Inc., et al. on 2017-06-05. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2017-01526
Filing Date
2017-06-05
Accorded Filing Date
2017-06-05
Institution Decision Date
2017-12-13
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2018-12-12
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc., et al.
Represented By
Guise, Jeffreyet alPatent Owner / Respondent
Sanofi Aventis Deutschland GmbH et al.
Represented By
Weiswasser, Elizabethet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 (Biotechnology & Organic Chemistry)
Decisions Rendered
0 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 36844 | Joseph Kirk Jr | +1 908-981-6911 |
| 39150 | John Conway | +1 908-981-6688 |
| 40564 | Anne Collins | +1 978-341-0036 |
| 44045 | Sandra Brockman-Lee | +1 857-523-9199 |
| 45736 | Pamela Torpey | +1 508--27-1-0683 |
| 45979 | Milan Vinnola | +1 619-238-0062 |
| 47150 | Nicole Parsons | +1 617-685-5697 |
| 52610 | Kelly Bender | +1 248-593-0581 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐ฉ๐ช Germany | Germany Counterpart | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → |
Mylan Pharmaceuticals Inc., et al. v. Sanofi Aventis Deutschland GmbH et al.